BioVie launches up to $6.46 million ATM equity program
BioVie entered a sales agreement to establish an at-the-market (ATM) equity program for up to $6,464,341 of Class A common stock for general corporate purposes, with shares sold through A.G.P./Alliance Global Partners.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.